ENTOD Pharmaceuticals Launches National Myopia Awareness Campaign to Combat Rising Myopia in India

ENTOD Pharmaceuticals, in collaboration with the MATANAND Welfare Foundation and the Paediatric Ophthalmological Society of India (SPOSI), will kick off its annual nationwide campaign to tackle the growing issue of myopia in India. The campaign, set to run from Children’s Day on 14th November for an entire week, aims to raise awareness about prevention, early detection, and management of myopia through outreach activities across the country.

With studies indicating a steep rise in myopia globally, India is facing alarming rates, particularly among urban children aged 5 to 15. Projections suggest that by 2030, nearly one-third of children in this age group may be affected, largely due to lifestyle habits and increased screen time. A report in the British Journal of Ophthalmology highlights that one in three young people worldwide now has myopia, and by 2050, nearly 49% of India’s youth may experience the condition. ENTOD’s campaign responds to this pressing need for action on eye health and the prevention of future ocular issues.

At a media roundtable held recently in Mumbai, campaign strategies were outlined by ENTOD CEO Mr. Nikkhil K Masurkar, along with expert panelists Dr. Siddharth Kesarwani, Dr. Jay Goyal, Dr. Pooja Ghalla Gogri, and Dr. Chandrashekhar Chawan. Mr. Masurkar stressed the campaign’s significance, saying, “The rapid increase in myopia, particularly among children, demands urgent public health attention. Educating families on preventive measures and encouraging regular eye checkups are essential steps in reducing myopia’s impact. This campaign represents ENTOD’s commitment to promoting eye health through awareness and accessible care.”

Since its inception, National Myopia Week has reached over 30 million parents, teachers, and students nationwide, using social media, press, and school programs to make a substantial impact. This year, ENTOD aims to further expand its reach by enlisting over 1,000 doctors and mobilizing 5,000 to 10,000 volunteers to lead awareness events. Planned activities include free eye screenings and interactive sessions at schools, clinics, and hospitals. Educational materials in multiple regional languages, free sample distributions, and radio programs in major cities will also amplify the campaign’s message.

Covering key locations like Mumbai, Delhi, Chennai, Hyderabad, and Jaipur, ENTOD’s initiative is designed for broad community engagement. Dr. Jitendra Jethani, a participating pediatric ophthalmologist from Vadodara, emphasized the importance of early intervention, saying, “Regular screenings, reducing screen time, and promoting outdoor activities are essential to slow myopia progression. Through ENTOD’s campaign, we aim to equip communities with the tools to safeguard vision.”

ENTOD Pharmaceuticals is dedicated to raising awareness of myopia’s risks and promoting proactive steps for healthier vision among India’s children and youth.

_{Images are for reference only.Images and contents gathered automatic from google or 3rd party sources.All rights on the images and contents are with their legal original owners.}